Advancing AAV: Novel Sequencing Solutions for Quality Control in Gene Therapy
Presenter: Aleksandar Janjic, Ph.D., NGS Study Manager
Harnessing the Power of Multiomics from a Single Sample with Advanced Automation for Sample Handling and Processing
Presenter: Andrea O'Hara, Ph.D., Strategic Technical Specialist
Benchmarking NGS Integration Site Analysis Methods in Support of Long-Term Safety Monitoring of Cell and Gene Therapy Products
Presenter: Ben Niu, Ph.D., Clinical Study Manager
GENEWIZ PLASMID-EZ
Verifying whole plasmids is now easier than ever with the unparalleled convenience of Plasmid-EZ, the newest addition to our suite of plasmid solutions. Leveraging long-read NGS, Plasmid-EZ is a complete plasmid-to-data method offering cost-effective, rapid, and high-throughput verification of plasmid integrity and fidelity. Simply submit your samples at any one of our convenient dropbox locations in our expansive network, and you’ll receive an interactive data report in as fast as 1 business day.
GENEWIZ AAV PACKAGING
Achieve AAV research success with absolute ITR accuracy by leveraging the new GENEWIZ AAV Packaging service from Azenta Life Sciences. AAV Packaging takes your project from codon-optimized construct design to one of over 20 high-quality viral serotypes with complete ITR integrity thanks to our proprietary ITR sequencing, correction, synthesis, and plasmid preparation methodology.
GENEWIZ INTEGRATION SITE ANALYSIS (ISA)
Do you use viral vectors in cell and gene therapeutic development? Integration site analysis (ISA) is a critical component of patient safety testing of these therapies. Protect your patient and the success of your trial by implementing our pre-optimized ISA protocols through pre-clinical and clinical sample collection and management.
